Institute of Cardiovascular Research Royal Holloway, University of London (ICR2UL), London, UK.
Fondazione IRCCS Ca'Granda - Ospedale Maggiore Policlinico, A. Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy.
Eur Stroke J. 2023 Mar;8(1):344-350. doi: 10.1177/23969873221148267. Epub 2023 Jan 6.
Cerebral venous thrombosis (CVT) is an uncommon cause of stroke in young adults. We aimed to determine the impact of age, gender and risk factors (including sex-specific) on CVT onset.
We used data from the BEAST (Biorepository to Establish the Aetiology of Sinovenous Thrombosis), a multicentre multinational prospective observational study on CVT. Composite factors analysis (CFA) was performed to determine the impact on the age of CVT onset in males and females.
A total of 1309 CVT patients (75.3% females) aged ⩾18 years were recruited. The overall median (IQR-interquartile range) age for males and females was 46 (35-58) years and 37 (28-47) years ( < 0.001), respectively. However, the presence of antibiotic-requiring sepsis ( = 0.03, 95% CI 27-47 years) among males and gender-specific risk factors like pregnancy ( < 0.001, 95% CI 29-34 years), puerperium ( < 0.001, 95% CI 26-34 years) and oral contraceptive use ( < 0.001, 95% CI 33-36 years) were significantly associated with earlier onset of CVT among females. CFA demonstrated a significantly earlier onset of CVT in females, ~12 years younger, in those with multiple (⩾1) compared to '0' risk factors ( < 0.001, 95% CI 32-35 years).
Women suffer CVT 9 years earlier in comparison to men. Female patients with multiple (⩾1) risk factors suffer CVT ~12 years earlier compared to those with no identifiable risk factors.
脑静脉血栓形成(CVT)是青年卒中的一个不常见病因。我们旨在确定年龄、性别和危险因素(包括性别特异性因素)对 CVT 发病的影响。
我们使用了来自 BEAST(建立静脉窦血栓形成病因的生物标本库)的多中心、多国前瞻性观察性 CVT 研究的数据。复合因素分析(CFA)用于确定年龄对男性和女性 CVT 发病的影响。
共纳入 1309 例年龄 ⩾18 岁的 CVT 患者(75.3%为女性)。男性和女性的总体中位(IQR-四分位间距)年龄分别为 46(35-58)岁和 37(28-47)岁( <0.001)。然而,男性中需要抗生素治疗的败血症( = 0.03,95%CI 27-47 岁)和女性中特定于性别的危险因素如妊娠( < 0.001,95%CI 29-34 岁)、产褥期( < 0.001,95%CI 26-34 岁)和口服避孕药使用( < 0.001,95%CI 33-36 岁)与 CVT 发病年龄更早显著相关。CFA 显示,与女性中“0”个危险因素相比,具有多个(⩾1)危险因素的女性 CVT 发病年龄显著提前,约早 12 岁( < 0.001,95%CI 32-35 岁)。
与男性相比,女性发生 CVT 早 9 年。与无明确危险因素的女性患者相比,具有多个(⩾1)危险因素的女性患者发生 CVT 早约 12 年。